SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001493152-19-006942
Filing Date
2019-05-13
Accepted
2019-05-13 17:14:26
Documents
1
Period of Report
2019-05-13
Effectiveness Date
2019-05-13

Document Format Files

Seq Description Document Type Size
1 def14c.htm DEF 14C 145847
  Complete submission text file 0001493152-19-006942.txt   147202
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 000-52218 | Film No.: 19819370
SIC: 2834 Pharmaceutical Preparations